Anti-HER2 Therapy Beyond Second-Line for HER2-Positive Metastatic Breast Cancer: A Short Review and Recommendations for Several Clinical Scenarios from a Spanish Expert Panel.

Noelia Martínez-Jañez,Ignacio Chacón,Ana de Juan,Luis Cruz-Merino,Sonia Del Barco,Isaura Fernández,Paula García-Teijido,Amalia Gómez Bernal,Arrate Plazaola,Jose Ponce,Sonia Servitja,P. Zamora

Anti-HER2 Therapy Beyond Second-Line for HER2-Positive Metastatic Breast Cancer: A Short Review and Recommendations for Several Clinical Scenarios from a Spanish Expert Panel.

2016

Noelia Martínez-Jañez
Ignacio Chacón
Ana de Juan
Luis Cruz-Merino
Sonia Del Barco
Isaura Fernández
Paula García-Teijido
Amalia Gómez Bernal
Arrate Plazaola
Jose Ponce
Sonia Servitja
P. Zamora

Background: The aim of this project was to provide an expert opinion regarding anti-human epidermal growth factor receptor 2 (HER2) therapy beyond second-line tre

Keywords:

Gynecology
Pathology
Clinical Practice
Epidermal growth factor receptor
Medicine
Metastatic breast cancer
Disease
Internal medicine
Lapatinib
Clinical trial
Blockade
Chemotherapy
Metastasis
Trastuzumab emtansine
Oncology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations